Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)
China · Delayed Price · Currency is CNY 21.49
+0.30 (1.42%)
Jul 15, 2026, 3:04 PM CST
SHE:002880 Market Cap
SHE:002880 has a market cap or net worth of 4.87 billion as of July 14, 2026. Its market cap has decreased by -23.90% in one year.
Market Cap
4.87B
Enterprise Value
5.64B
Revenue
1.26B
Ranking
n/a
PE Ratio
20.87
Stock Price
21.49
Market Cap Chart
Since June 16, 2017, SHE:002880's market cap has increased from 3.91B to 4.87B, an increase of 24.80%. That is a compound annual growth rate of 2.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 4.87B | -15.73% |
| Dec 31, 2025 | 5.78B | -5.59% |
| Dec 31, 2024 | 6.13B | -23.11% |
| Dec 29, 2023 | 7.97B | 10.16% |
| Dec 30, 2022 | 7.23B | -0.90% |
| Dec 31, 2021 | 7.30B | -6.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaResources (Shanghai) | 5.34B |
| Novogene | 5.19B |
| Hangzhou Biotest Biotech | 5.08B |
| Zhejiang Wecome Pharmaceutical Company | 4.93B |
| R&G PharmaStudies | 4.91B |
| Xiangxue Pharmaceutical | 4.85B |
| Hefei Lifeon Pharmaceutical | 4.70B |
| Wuhan Hvsen Biotechnology | 4.60B |